“…It is characterized by gasdermin family-mediated pore formation on the plasma membrane, cell swelling, and eventual lysis, followed by release of cellular contents, especially inflammatory mediators IL-1 β and IL-18 [83]. Although pyroptosis was first described in macrophage infected with Shigella flexneri in 1992 [84], it can also occur in monocytes, dendritic cells, CD4 + T cells, hepatocytes, vascular endothelial cells (VECs), tubular epithelial cells, and many other cell types [85–89]. To date, three pathways have been reported to participate in pyroptosis, including the caspase-1-dependent canonical pathway, the noncanonical pathway involving caspase-4,5 (for human) or caspase-11 (for mouse), and the newly discovered caspase-3-dependent pathway.…”